Zobrazeno 1 - 10
of 329 461
pro vyhledávání: '"targeted"'
Autor:
Peng M; Department of Pharmacy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, P. R. China. meipeng@csu.edu.cn., Deng J; Department of Pharmacy, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan, 410000, P. R. China., Li X; Department of Pharmacy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, P. R. China. Xylxping@csu.edu.cn.
Publikováno v:
Molecular cancer [Mol Cancer] 2024 Nov 15; Vol. 23 (1), pp. 256. Date of Electronic Publication: 2024 Nov 15.
Autor:
Zeller SL; Department of Neurosurgery, Westchester Medical Center/New York Medical College, Valhalla, NY, U.S.A., Spirollari E; Department of Neurosurgery, Westchester Medical Center/New York Medical College, Valhalla, NY, U.S.A., Chandy AM; Department of Neurosurgery, Westchester Medical Center/New York Medical College, Valhalla, NY, U.S.A., Hanft SJ; Department of Neurosurgery, Westchester Medical Center/New York Medical College, Valhalla, NY, U.S.A., Gandhi CD; Department of Neurosurgery, Westchester Medical Center/New York Medical College, Valhalla, NY, U.S.A., Jhanwar-Uniyal M; Department of Neurosurgery, Westchester Medical Center/New York Medical College, Valhalla, NY, U.S.A. meena_jhanwar@nymc.edu.
Publikováno v:
Anticancer research [Anticancer Res] 2024 Nov; Vol. 44 (11), pp. 4677-4690.
Autor:
Benjamin DJ; Hoag Family Cancer Institute, Newport Beach, CA, United States. Electronic address: David.Benjamin@hoag.org., Prasad V; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Nov; Vol. 212, pp. 115058. Date of Electronic Publication: 2024 Sep 30.
Autor:
Bidikian A; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale New Haven Hospital, New Haven, CT, USA., Bewersdorf JP; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale New Haven Hospital, New Haven, CT, USA., Shallis RM; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale New Haven Hospital, New Haven, CT, USA., Getz TM; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale New Haven Hospital, New Haven, CT, USA., Stempel JM; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale New Haven Hospital, New Haven, CT, USA., Kewan T; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale New Haven Hospital, New Haven, CT, USA., Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Zeidan AM; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale New Haven Hospital, New Haven, CT, USA.
Publikováno v:
Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2024 Nov; Vol. 24 (11), pp. 1131-1146. Date of Electronic Publication: 2024 Oct 17.
Autor:
Xu Y; Department of Urology, Yantai Affiliated Hospital of Binzhou Medical University, The Second Clinical Medical College of Binzhou Medical University, Yantai, Shandong 264100, P.R. China., Zhang G; Department of Urology, Yantai Affiliated Hospital of Binzhou Medical University, The Second Clinical Medical College of Binzhou Medical University, Yantai, Shandong 264100, P.R. China., Liu Y; Department of Urology, Yantai Affiliated Hospital of Binzhou Medical University, The Second Clinical Medical College of Binzhou Medical University, Yantai, Shandong 264100, P.R. China., Liu Y; Department of Urology, Yantai Affiliated Hospital of Binzhou Medical University, The Second Clinical Medical College of Binzhou Medical University, Yantai, Shandong 264100, P.R. China., Tian A; Department of Urology, Yantai Affiliated Hospital of Binzhou Medical University, The Second Clinical Medical College of Binzhou Medical University, Yantai, Shandong 264100, P.R. China., Che J; Department of Urology, Yantai Affiliated Hospital of Binzhou Medical University, The Second Clinical Medical College of Binzhou Medical University, Yantai, Shandong 264100, P.R. China., Zhang Z; Department of Urology, Yantai Affiliated Hospital of Binzhou Medical University, The Second Clinical Medical College of Binzhou Medical University, Yantai, Shandong 264100, P.R. China.
Publikováno v:
International journal of oncology [Int J Oncol] 2024 Nov; Vol. 65 (5). Date of Electronic Publication: 2024 Sep 20.
Autor:
Sun SY; Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, USA. Electronic address: ssun@emory.edu.
Publikováno v:
Cancer letters [Cancer Lett] 2024 Nov 01; Vol. 604, pp. 217203. Date of Electronic Publication: 2024 Sep 03.
Autor:
Westphalen CB; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich; German Cancer Consortium (DKTK), partner site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: education@esmo.org., Martins-Branco D; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland., Beal JR; Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Cardone C; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori- IRCCS-Fondazione G. Pascale, Naples, Italy., Coleman N; School of Medicine, Trinity College Dublin, Dublin; Medical Oncology Department, St. James's Hospital, Dublin; Trinity St. James's Cancer Institute, Dublin, Ireland., Schram AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City; Weill Cornell Medical College, New York City., Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham; Duke Cancer Institute, Duke University, Durham, USA., Michiels S; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif, France., Yap C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., André F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre., Bibeau F; Service d'Anatomie Pathologique, CHU Besançon, Université de Bourgogne Franche-Comté, Besançon, France., Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Kummar S; Division of Hematology and Medical Oncology, Department of Medicine, Knight Cancer Institute, Oregon Health and Science University, Portland., Kurzrock R; Department of Medicine, Medical College of Wisconsin Cancer Center, Milwaukee, USA., Limaye S; Medical & Precision Oncology, Sir H. N. Reliance Foundation Hospital & Research Centre, Mumbai, India., Loges S; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), German Center for Lung Research (DZL), German Cancer Consortium (DKTK), Heidelberg, Germany., Marabelle A; Drug Development Department (DITEP) and Laboratory for Translational Research in Immunotherapy (LRTI), Gustave Roussy, INSERM U1015 & CIC1428, Université Paris-Saclay, Villejuif, France., Marchió C; Department of Medical Sciences, University of Turin, Turin; Division of Pathology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Rodon J; Department of Investigational Cancer Therapeutics, UT MD Anderson, Houston, USA., Spanic T; Europa Donna Slovenia, Ljubljana, Slovenia., Pentheroudakis G; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland., Subbiah V; Early-Phase Drug Development, Sarah Cannon Research Institute (SCRI), Nashville, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov; Vol. 35 (11), pp. 936-953. Date of Electronic Publication: 2024 Aug 25.
Autor:
Occhipinti M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Brambilla M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: marta.brambilla2@istitutotumori.mi.it., Di Liello R; UOC Oncologia, P.O. Ospedale del Mare, ASL Napoli 1, Naples, Italy., Ambrosini P; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Lobianco L; Medical Oncology, Precision Medicine Department, Università degli Studi della Campania 'Luigi Vanvitelli', Naples, Italy., Leporati R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Salvarezza M; Medical Oncology, Precision Medicine Department, Università degli Studi della Campania 'Luigi Vanvitelli', Naples, Italy., Vitiello F; Medical Oncology Unit, Ospedale Monaldi, AORN Ospedali dei Colli, Naples, Italy., Marchesi S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Manglaviti S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Beninato T; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Mazzeo L; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Proto C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Prelaj A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Electronics, Information and Bioengineering, Polytechnic University of Milan, Milan, Italy., Ferrara R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Della Corte CM; UOC Oncologia, P.O. Ospedale del Mare, ASL Napoli 1, Naples, Italy., Lo Russo G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., de Braud F; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Ganzinelli M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Viscardi G; Medical Oncology Unit, Ospedale Monaldi, AORN Ospedali dei Colli, Naples, Italy.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Nov; Vol. 203, pp. 104481. Date of Electronic Publication: 2024 Aug 17.
Autor:
Kala J; Division of Nephrology, Department of Internal Medicine, University of Texas Health Science Center-McGovern Medical School, Houston, Texas., Joseph T; Division of Nephrology, Department of Internal Medicine, University of Texas Health Science Center-McGovern Medical School, Houston, Texas.; Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Pirovano M; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Fenoglio R; University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Turin, Italy.; Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Cittàdi Torino, Turin, Italy.; Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy., Cosmai L; Onconephrology Outpatient Clinic, Nephrology and Dialysis Unit, ASST Fatebenefratelli Sacco, Milan, Italy.
Publikováno v:
Kidney360 [Kidney360] 2024 Nov 01; Vol. 5 (11), pp. 1750-1762. Date of Electronic Publication: 2024 Aug 26.
Autor:
Seront E; Center for Vascular Anomalies (a VASCERN VASCA European Reference Centre), Cliniques universitaires St Luc, University of Louvain, Brussels, Belgium. Electronic address: https://twitter.com/emmanuelseront., Hermans C; Center for Vascular Anomalies (a VASCERN VASCA European Reference Centre), Cliniques universitaires St Luc, University of Louvain, Brussels, Belgium; Institut Roi Albert II, Division of Hematology, Cliniques universitaires Saint-Luc, University of Louvain, Brussels, Belgium. Electronic address: https://twitter.com/HermansCedric., Boon LM; Center for Vascular Anomalies (a VASCERN VASCA European Reference Centre), Cliniques universitaires St Luc, University of Louvain, Brussels, Belgium; Division of Plastic Surgery, Cliniques universitaires Saint-Luc, University of Louvain, Brussels, Belgium. Electronic address: https://twitter.com/LaurenceBoon4., Vikkula M; Center for Vascular Anomalies (a VASCERN VASCA European Reference Centre), Cliniques universitaires St Luc, University of Louvain, Brussels, Belgium; Deprtment of Human Molecular Genetics, de Duve Institute, University of Louvain, Brussels, Belgium; Walloon ExceLlence in Life Sciences and Biotechnology (WELBIO) and Walloon ExceLlence Research Institute (WEL Research Institute), Wavre, Belgium. Electronic address: miikka.vikkula@uclouvain.be.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Nov; Vol. 22 (11), pp. 2961-2975. Date of Electronic Publication: 2024 Aug 02.